JPS56102787A - Preparation of human placenta superoxide dismutase - Google Patents

Preparation of human placenta superoxide dismutase

Info

Publication number
JPS56102787A
JPS56102787A JP348280A JP348280A JPS56102787A JP S56102787 A JPS56102787 A JP S56102787A JP 348280 A JP348280 A JP 348280A JP 348280 A JP348280 A JP 348280A JP S56102787 A JPS56102787 A JP S56102787A
Authority
JP
Japan
Prior art keywords
superoxide
dismutase
human placenta
precipitate
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP348280A
Other languages
Japanese (ja)
Inventor
Yoshimasa Itou
Itsuo Inoue
Kazuyuki Hirano
Mamoru Sugiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP348280A priority Critical patent/JPS56102787A/en
Publication of JPS56102787A publication Critical patent/JPS56102787A/en
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: To separate superoxide.dismutase from the supernatant liquid obtained by disintegrating the tissue of human placenta with an aqeous solution of potassium chloride or sodium chloride.
CONSTITUTION: The sufficiently blooded fresh human placenta obtained through normal delivery, or its frozen product is added with 5 times weigth of 1.15% potassium chloride solution or 0.9% sodium chloride solution, and maintained at 0W4°C to effect complete disintegration of the tissue. The precipitate is removed therfrom by centrifugal separation, and the supernatant liquid is heated at about 60W75°C for about 5min. The produced precipitate is removed by filtration, and the filtrate is mixed with ammonium solfate solution of 50W90% saturation. The precipitate is dissolved and dialyzed, and the dialyzate is subjected to ion exchange Sephadex chromatography or treated with a carrier bonded with superoxide.dismutase antibody, to obtain mitochondrian.superoxide.dismutase and soluble fraction of superoxide.dismutase.
COPYRIGHT: (C)1981,JPO&Japio
JP348280A 1980-01-18 1980-01-18 Preparation of human placenta superoxide dismutase Pending JPS56102787A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP348280A JPS56102787A (en) 1980-01-18 1980-01-18 Preparation of human placenta superoxide dismutase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP348280A JPS56102787A (en) 1980-01-18 1980-01-18 Preparation of human placenta superoxide dismutase

Publications (1)

Publication Number Publication Date
JPS56102787A true JPS56102787A (en) 1981-08-17

Family

ID=11558548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP348280A Pending JPS56102787A (en) 1980-01-18 1980-01-18 Preparation of human placenta superoxide dismutase

Country Status (1)

Country Link
JP (1) JPS56102787A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925682A (en) * 1982-08-04 1984-02-09 Toyo Soda Mfg Co Ltd Separation and purification of cu, zn-superoxide dismutase
JPS62289187A (en) * 1985-11-22 1987-12-16 バイオ−テクノロジ−・ジエネラル・コ−ポレイシヨン Human manganese superoxide dismutase cdna, it development inbacteria and recovery of enzyme active human manganese superoxide dismutase
US5130245A (en) * 1985-09-03 1992-07-14 Stefan Marklund Superoxide dismutase
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925682A (en) * 1982-08-04 1984-02-09 Toyo Soda Mfg Co Ltd Separation and purification of cu, zn-superoxide dismutase
JPH03994B2 (en) * 1982-08-04 1991-01-09 Tosoh Corp
US5130245A (en) * 1985-09-03 1992-07-14 Stefan Marklund Superoxide dismutase
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
US5472691A (en) * 1985-09-03 1995-12-05 Symbicom Aktiebolag Superoxide dismutase
US5788961A (en) * 1985-09-03 1998-08-04 Symbicom Aktiebolag Superoxide dismutase
JPS62289187A (en) * 1985-11-22 1987-12-16 バイオ−テクノロジ−・ジエネラル・コ−ポレイシヨン Human manganese superoxide dismutase cdna, it development inbacteria and recovery of enzyme active human manganese superoxide dismutase

Similar Documents

Publication Publication Date Title
IE802744L (en) Platinum (iv)-diamine complexes
EP0254289A3 (en) Agent for the treatment of arthrosis
GB1446284A (en) Neurotoxin
JPS5743695A (en) Preparation of human follicle-stimulating hormone
Barnes et al. Hydroxylysine in the N-terminal regions of the α1-and α2-chains of various collagens
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
JPS56102787A (en) Preparation of human placenta superoxide dismutase
JPS5359018A (en) Concentrated xiii-th blood coagulating factor derived from human placentaand its preparation
JPS5712993A (en) Isolation of superoxide dismutase
DK12388A (en) SIALOSYL CHOLESTEROL, PROCEDURES FOR THE PREPARATION OF AND NEUROPATIMIDE COMPREHENSIVE SAME
EP0100366A1 (en) Agent for treating allergic disease, immunity complex disease, and tumour
CA1207262A (en) Human leucocyte pepsin-like enzyme, method for preparation of the enzyme, and method and therapeutic agent for treating allergic disorders, immune complex diseases and tumors containing the same as an effective ingredient
JPS61200923A (en) Substance having antiallergic action and production thereof
GB1564592A (en) Arterial polysaccharide complex process for its preparation and its use in human therapy
JPS568686A (en) Preparation of galactose oxidase
Santini et al. Increasing antigenecity of B16 melanoma cell fraction with microwave hyperthermia
JPS56125310A (en) Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin
JPS5535004A (en) Cell-immunity activator and its preparation
Daly et al. C-type virus-like particles in a non-proliferating sparganum of human host origin
JPS52125481A (en) Water-dispersible absorbers for blood et al.
JPS53127808A (en) Preparation of human albumin
EP0027429A2 (en) A process for preparing tumor antidotes (oncoclasines) from the excrements of goats
JPS5733568A (en) Preparation of "konjak" (devil's-tongue jelly) containing tea made from mugwort
SU1042752A1 (en) Method of treating chronic urethritis
JPS5649394A (en) Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity